Since founded in 1996, NTL has grown to be a leader in the field of cervical cancer screening. In 2004, NTL has developed the remote cervical cancer screening system, TeleCervico® for the first time in the world and has been supplying it for hospitals and clinics. This system represents a breakthrough in cervical cancer examination as it makes the existing off-line examination possible on line using Internet. Based on the technology and know-how accumulated in the service of cervical cancer examination for the last 14 years and continuous challenging spirit, NTL will take the initiative in global cervical cancer screening market by integrating all the cervical cancer-related examinations and strengthening precision control. NTL is presented the thesis of the excellent clinical effects of TeleCervico® to ASCCP(American Society of Colposcopy & Cervical Pathology) and to FIGO and selected as the Korean World-class Product by the Government